Cambridge Investment Research Advisors
NGM

Cambridge Investment Research Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,306
Closed -$241K – 3183
2021
Q1 		$241K Hold
8,306
– – ﹤0.01% 2459
2020
Q4 		$252K Buy
+8,306
New +$252K ﹤0.01% 2283